Saudi Arabia Pharma To Join In Creating Malaysia's First Vaccine Facility
This article was originally published in PharmAsia News
Executive Summary
Saudi Arabia's Al-Jomiah Pharma Holding agreed to join Malaysian Biotechnology to build the nation's first vaccine-production facility, expected to be operational in 2016.
You may also be interested in...
QUOTED. 18 January 2021. Chad Reynolds.
Chad Reynolds of RMQ+ spoke to Medtech Insight about practical strategies for managing economic operators efficiently and with a view to long-term compliance.
Dr Reddy’s Wants To Break Into Top Five In India
Dr Reddy’s signals a sharp step up in ambitions at home, propelled by building leadership in 10 therapy segments and an “India-first” approach for specialty products. Uptick in the China business and the potential launch of a Russia-partnered COVID-19 vaccine were other aspects of the business discussed at JPM.
Quick Listen: Scrip’s Five Must-Know Things
Join us for an audio catch-up on the latest key developments in the global biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.
Need a specific report? 1000+ reports available
Buy Reports